
Novo Nordisk is a global healthcare company driving change to defeat chronic diseases through innovation.
The Rare Disease organization leads all US Commercial efforts for Novo Nordisk’s Rare Disease portfolio. The Rare Disease organization is responsible for leading the enterprise approach to achieving our patient care goals and financial objectives, devising and delivering transformative patient and customer experiences, addressing unmet needs across the communities we serve, and setting the industry standard for extraordinary execution.
Novo Nordisk is a global healthcare company driving change to defeat chronic diseases through innovation.